170 related articles for article (PubMed ID: 19944976)
1. Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy.
Yang I; Huh NG; Smith ZA; Han SJ; Parsa AT
Neurosurg Clin N Am; 2010 Jan; 21(1):181-6. PubMed ID: 19944976
[TBL] [Abstract][Full Text] [Related]
2. The use of sodium MRI in the diagnosis of an anaplastic astrocytoma during immunotherapy: a case report.
De Leon-Benedetti L; Narayanan S; Lee VK; Panigrahy A; Boada F; Bhatia A
Childs Nerv Syst; 2024 Mar; 40(3):965-967. PubMed ID: 37878058
[TBL] [Abstract][Full Text] [Related]
3. Neuroimaging findings of the post-treatment effects of radiation and chemotherapy of malignant primary glial neoplasms.
Mamlouk MD; Handwerker J; Ospina J; Hasso AN
Neuroradiol J; 2013 Aug; 26(4):396-412. PubMed ID: 24007728
[TBL] [Abstract][Full Text] [Related]
4. Selective Cell Size MRI Differentiates Brain Tumors from Radiation Necrosis.
Devan SP; Jiang X; Luo G; Xie J; Quirk JD; Engelbach JA; Harmsen H; McKinley ET; Cui J; Zu Z; Attia A; Garbow JR; Gore JC; McKnight CD; Kirschner AN; Xu J
Cancer Res; 2022 Oct; 82(19):3603-3613. PubMed ID: 35877201
[TBL] [Abstract][Full Text] [Related]
5. MR spectroscopy in radiation injury.
Sundgren PC
AJNR Am J Neuroradiol; 2009 Sep; 30(8):1469-76. PubMed ID: 19369613
[TBL] [Abstract][Full Text] [Related]
6. Glioma surveillance imaging: current strategies, shortcomings, challenges and outlook.
Abdalla G; Hammam A; Anjari M; D'Arco DF; Bisdas DS
BJR Open; 2020; 2(1):20200009. PubMed ID: 33178973
[TBL] [Abstract][Full Text] [Related]
7. Information-Based Medicine in Glioma Patients: A Clinical Perspective.
Senders JT; Harary M; Stopa BM; Staples P; Broekman MLD; Smith TR; Gormley WB; Arnaout O
Comput Math Methods Med; 2018; 2018():8572058. PubMed ID: 30008798
[TBL] [Abstract][Full Text] [Related]
8. Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas.
Zikou A; Sioka C; Alexiou GA; Fotopoulos A; Voulgaris S; Argyropoulou MI
Contrast Media Mol Imaging; 2018; 2018():6828396. PubMed ID: 30627060
[TBL] [Abstract][Full Text] [Related]
9. Imaging Glioblastoma Posttreatment: Progression, Pseudoprogression, Pseudoresponse, Radiation Necrosis.
Strauss SB; Meng A; Ebani EJ; Chiang GC
Radiol Clin North Am; 2019 Nov; 57(6):1199-1216. PubMed ID: 31582045
[TBL] [Abstract][Full Text] [Related]
10. Conventional and Advanced Imaging Techniques in Post-treatment Glioma Imaging.
Li AY; Iv M
Front Radiol; 2022; 2():883293. PubMed ID: 37492665
[TBL] [Abstract][Full Text] [Related]
11. Case series review of neuroradiologic changes associated with immune checkpoint inhibitor therapy.
Gatson NTN; Makary M; Bross SP; Vadakara J; Maiers T; Mongelluzzo GJ; Leese EN; Brimley C; Fonkem E; Mahadevan A; Sarkar A; Panikkar R
Neurooncol Pract; 2021 Jun; 8(3):247-258. PubMed ID: 34055372
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the diagnostic performance of diffusion magnetic resonance imaging with apparent diffusion coefficient measurements for differentiating glioma recurrence from pseudoprogression.
Yu Y; Ma Y; Sun M; Jiang W; Yuan T; Tong D
Medicine (Baltimore); 2020 Jun; 99(23):e20270. PubMed ID: 32501974
[TBL] [Abstract][Full Text] [Related]
13. Advanced magnetic resonance spectroscopic neuroimaging: Experts' consensus recommendations.
Maudsley AA; Andronesi OC; Barker PB; Bizzi A; Bogner W; Henning A; Nelson SJ; Posse S; Shungu DC; Soher BJ
NMR Biomed; 2021 May; 34(5):e4309. PubMed ID: 32350978
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric MRI for early identification of therapeutic response in recurrent glioblastoma treated with immune checkpoint inhibitors.
Song J; Kadaba P; Kravitz A; Hormigo A; Friedman J; Belani P; Hadjipanayis C; Ellingson BM; Nael K
Neuro Oncol; 2020 Nov; 22(11):1658-1666. PubMed ID: 32193547
[TBL] [Abstract][Full Text] [Related]
15. Preclinical MRI: Studies of the irradiated brain.
Garbow JR; Tsien CI; Beeman SC
J Magn Reson; 2018 Jul; 292():73-81. PubMed ID: 29705034
[TBL] [Abstract][Full Text] [Related]
16. Imaging in neuro-oncology.
Nandu H; Wen PY; Huang RY
Ther Adv Neurol Disord; 2018; 11():1756286418759865. PubMed ID: 29511385
[TBL] [Abstract][Full Text] [Related]
17. Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases.
Ranjan S; Quezado M; Garren N; Boris L; Siegel C; Lopes Abath Neto O; Theeler BJ; Park DM; Nduom E; Zaghloul KA; Gilbert MR; Wu J
BMC Cancer; 2018 Mar; 18(1):239. PubMed ID: 29490632
[TBL] [Abstract][Full Text] [Related]
18. High-grade glioma management and response assessment-recent advances and current challenges.
Khan MN; Sharma AM; Pitz M; Loewen SK; Quon H; Poulin A; Essig M
Curr Oncol; 2016 Aug; 23(4):e383-91. PubMed ID: 27536188
[TBL] [Abstract][Full Text] [Related]
19. A Novel Methodology for Applying Multivoxel MR Spectroscopy to Evaluate Convection-Enhanced Drug Delivery in Diffuse Intrinsic Pontine Gliomas.
Guisado DI; Singh R; Minkowitz S; Zhou Z; Haque S; Peck KK; Young RJ; Tsiouris AJ; Souweidane MM; Thakur SB
AJNR Am J Neuroradiol; 2016 Jul; 37(7):1367-73. PubMed ID: 26939629
[TBL] [Abstract][Full Text] [Related]
20. Parametric Response Mapping of Apparent Diffusion Coefficient as an Imaging Biomarker to Distinguish Pseudoprogression from True Tumor Progression in Peptide-Based Vaccine Therapy for Pediatric Diffuse Intrinsic Pontine Glioma.
Ceschin R; Kurland BF; Abberbock SR; Ellingson BM; Okada H; Jakacki RI; Pollack IF; Panigrahy A
AJNR Am J Neuroradiol; 2015 Nov; 36(11):2170-6. PubMed ID: 26338910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
